Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Wozniak, A. J.; Schneider, B. J.; Kalemkerian, G. P.; Daly, R. M.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Validation of broad panel clinical sequencing-based genomic risk stratification in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Whipple, S.; Martin, A.; Martinec, M.; Arbour, K. C.; Seshan, V. E.; Riely, G. J.; Crane, G.; Shen, R.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer
    Meeting Abstract

    Skoulidis, F.; Arbour, K. C.; Hellmann, M. D.; Patil, P. D.; Marmarelis, M. E.; Awad, M. M.; Murray, J. C.; Hellyer, J.; Gainor, J. F.; Dimou, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: Integrated analysis from three clinical trials
    Meeting Abstract

    Siena, S.; Doebele, R. C.; Shaw, A. T.; Karapetis, C. S.; Tan, D. S. W.; Cho, B. C.; Kim, D. W.; Ahn, M. J.; Krebs, M.; Goto, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Early circulating tumor (ct)DNA dynamics and efficacy of lorlatinib in patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Shaw, A. T.; Martini, J. F.; Besse, B.; Bauer, T. M.; Lin, C. C.; Soo, R. A.; Riely, G. J.; Ou, S. H. I.; Abbattista, A.; Toffalorio, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics of NRG1 fusion-positive cancers: A single-institution study
    Meeting Abstract

    Schram, A. M.; Benayed, R.; Somwar, R.; Rekhtman, N.; Arcila, M. E.; Ladanyi, M.; Hyman, D. M.; Drilon, A. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer
    Meeting Abstract

    Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response
    Meeting Abstract

    Reuss, J. E.; Smith, K. N.; Anagnostou, V.; Zhang, J.; Zahurak, M.; Caushi, J.; Chan, H. Y.; Guo, H.; Hellmann, M. D.; Pardoll, D. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world utilization of EGFR TKI therapies and treatment outcomes in patients with advanced EGFR-sensitizing mutation-positive NSCLC
    Meeting Abstract

    Riely, G. J.; Lovly, C. M.; Messina, C. G. M.; Bienert, S.; Alexander, K.; Pao, W.; Baxi, S.; Doebele, R. C.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save